TRIANA Biomedicines
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $43M
Investors
- 6
About TRIANA Biomedicines
Founded in 2019 and based in Massachusetts, US, TRIANA Biomedicines, Inc. is a biopharmaceutical company that develops a molecular glue discovery platform to help regulate disease. In April 2022, TRIANA Biomedicines, Inc. As of 2022, Patrick Trojer is the president and CEO of the company. The company offers a technology that enables the identification of molecules that promote the interaction of a target and another protein in such a way that the fate or function of the target protein is altered. The firm's rational approach to molecular glue discovery is centered on inducing or enhancing the degradation of high-profile cancer targets.
Who invested in TRIANA Biomedicines
6 investors across 2 rounds
See all investors in TRIANA Biomedicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TRIANA Biomedicines
Who invested in TRIANA Biomedicines?
TRIANA Biomedicines has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TRIANA Biomedicines raised?
TRIANA Biomedicines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TRIANA Biomedicines last raise money?
TRIANA Biomedicines's most recent round on record is a Series A, in Apr 2022.
What does TRIANA Biomedicines do?
Founded in 2019 and based in Massachusetts, US, TRIANA Biomedicines, Inc.
Where is TRIANA Biomedicines headquartered?
TRIANA Biomedicines is headquartered in Waltham, US.
Which VCs invest in companies like TRIANA Biomedicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TRIANA Biomedicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like TRIANA Biomedicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.